"Phase 2" trang 1 - tải miễn phí từ tailieunhanh
Optimal biological dose: A systematic review in cancer phase I clinical trials

Optimal biological dose: A systematic review in cancer phase I clinical trials
10    30    1
A Phase 2a cohort expansion study to assess the safety, tolerability, and preliminary efficacy of CXD101 in patients with advanced solid-organ cancer expressing HR23B or lymphoma

A Phase 2a cohort expansion study to assess the safety, tolerability, and preliminary efficacy of CXD101 in patients with advanced solid-organ cancer expressing HR23B or lymphoma
10    21    1
Ebook Electrical and electronic principles and technology (3/E): Part 2

Ebook Electrical and electronic principles and technology (3/E): Part 2
203    4    1
Ebook Electrical and electronic principles and technology (3/E): Part 2

Ebook Electrical and electronic principles and technology (3/E): Part 2
203    4    1
Lecture Oil and gas field processing - Chapter 2: Phase separation

Lecture Oil and gas field processing - Chapter 2: Phase separation
39    11    1
Ebook Electricity 4 - AC/DC motors, controls, and maintenance (9/E): Part 2

Ebook Electricity 4 - AC/DC motors, controls, and maintenance (9/E): Part 2
212    1    1
Ebook Electricity 4 - AC/DC motors, controls, and maintenance (9/E): Part 2

Ebook Electricity 4 - AC/DC motors, controls, and maintenance (9/E): Part 2
212    1    1
A total synthesis of cyclodepsipeptide [Leu]6-aureobasidin K using combination solid- and solution-phase

A total synthesis of cyclodepsipeptide [Leu]6-aureobasidin K using combination solid- and solution-phase
8    67    0
Ebook Engineering materials (2nd edition - Volume 2): Part 1

Ebook Engineering materials (2nd edition - Volume 2): Part 1
226    64    0
Two mode- (de)muxer based on a symmetric Y junction coupler, A2×2 mmi coupler and a ridge phase shifter using silicon waveguides for WDM applications

Two mode- (de)muxer based on a symmetric Y junction coupler, A2×2 mmi coupler and a ridge phase shifter using silicon waveguides for WDM applications
12    228    0
Efficacy and safety of concurrent chemoradiotherapy in ECOG 2 patients with locally advanced non-small-cell lung cancer: A subgroup analysis of a randomized phase III trial

Efficacy and safety of concurrent chemoradiotherapy in ECOG 2 patients with locally advanced non-small-cell lung cancer: A subgroup analysis of a randomized phase III trial
10    96    0
Gemcitabine and docetaxel combination chemotherapy for advanced bone and soft tissue sarcomas: Protocol for an open-label, non-randomised, Phase 2 study

Gemcitabine and docetaxel combination chemotherapy for advanced bone and soft tissue sarcomas: Protocol for an open-label, non-randomised, Phase 2 study
6    65    1
Effcacy and safety of pomalidomide and low-dose dexamethasone in Chinese patients with relapsed or refractory multiple myeloma: A multicenter, prospective, single-arm, phase 2 trial

Effcacy and safety of pomalidomide and low-dose dexamethasone in Chinese patients with relapsed or refractory multiple myeloma: A multicenter, prospective, single-arm, phase 2 trial
9    14    1
Sintilimab plus nab-paclitaxel as second-line treatment for advanced biliary tract cancer: Study protocol for an investigator-initiated phase 2 trial (NapaSinti trial)

Sintilimab plus nab-paclitaxel as second-line treatment for advanced biliary tract cancer: Study protocol for an investigator-initiated phase 2 trial (NapaSinti trial)
7    1    1
Two Phase Flow Phase Change and Numerical Modeling Part 2

Two Phase Flow Phase Change and Numerical Modeling Part 2
30    44    0
Ebook Thermodynamics and chemistry: Part 2

Ebook Thermodynamics and chemistry: Part 2
311    63    0
Ebook Fundamentals of materials science and engineering (5th edition): Part 2

Ebook Fundamentals of materials science and engineering (5th edition): Part 2
463    63    0
Two open-label, single arm, non-randomized phase II studies of irinotecan for the treatment of metastatic breast cancer in patients with increased copy number of the topoisomerase I gene

Two open-label, single arm, non-randomized phase II studies of irinotecan for the treatment of metastatic breast cancer in patients with increased copy number of the topoisomerase I gene
5    70    0
Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: A multicentre, randomised controlled openlabel phase II trial

Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: A multicentre, randomised controlled openlabel phase II trial
10    34    1
A phase IA dose-escalation study of PHI101, a new checkpoint kinase 2 inhibitor, for platinum-resistant recurrent ovarian cancer

A phase IA dose-escalation study of PHI101, a new checkpoint kinase 2 inhibitor, for platinum-resistant recurrent ovarian cancer
7    31    3